Medications

GLP-1 is a peptide proven to be an effective treatment for diabetes and weight management. However, taking any peptide that has not been approved as a medication is risky and potentially ineffective.

Off-label use of medications like Ozempic, Wegovy, Mounjaro, and Zepbound is becoming increasingly common to address weight management, insulin resistance, and diabetes related complications in type 1 diabetes. New expert recommendations provide a framework for safe use while large trials are ongoing. 

There have never been more options for tracking blood sugar and delivering insulin. Depending on insurance, cost, and availability, people with diabetes may be able to try different CGM, insulin pumps, and AID systems and figure out what works for them.

People with difficult-to-manage high blood pressure have a new treatment option with the recent FDA approval of Baxfendy (baxdrostat).

When traveling by air, people with diabetes have a right to bring everything they need on the plane with them, but getting medical supplies through an airport requires preparation and clear communication.

This clinical trial is comparing the safety and effectiveness of once-weekly insulin icodec to daily insulin glargine for people with type 1 diabetes.